Compare GE Vernova Inc (GEV) vs Neurocrine Biosciences Inc (NBIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE Vernova Inc vs Neurocrine Biosciences Inc — how do they compare? GE Vernova Inc trades at $1,026 (market cap $269.50B), while Neurocrine Biosciences Inc trades at $155.01 (market cap $16.46B). The key difference: GE Vernova Inc is far larger — about 16.4× Neurocrine Biosciences Inc's market cap, and GE Vernova Inc pays a 0.2% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals.
| GEV | NBIX | |
|---|---|---|
Market Cap | $269.50B | $16.46B |
Sector | Technology | Health |
52-Week High | $1.17K | $185.50 |
52-Week Low | $547.96 | $123.10 |
Enterprise Value | $259.17B | $16.48B |
Dividend Yield | 0.2% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GE Vernova Inc
GE Vernova is a global leader in the electric power industry. It provides sustainable energy solutions across gas, wind, and hydro sectors, focusing on modernizing the world's power grids.
Read more on GEV →About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →
